DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Linsitinib is an investigational drug.
There have been 8 clinical trials for Linsitinib. The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2009.
The most common disease conditions in clinical trials are Carcinoma, Adenocarcinoma, and Paraganglioma. The leading clinical trial sponsors are National Cancer Institute (NCI), Astellas Pharma Inc, and Oxford University Hospitals NHS Trust.
Recent Clinical Trials for Linsitinib
|A Rollover Study for Subjects That Have Participated in an Astellas Sponsored Linsitinib Trial||Astellas Pharma Global Development, Inc.||Phase 2|
|Eurosarc Trial of Linsitinib in Advanced Ewing Sarcoma||Astellas Pharma Inc||Phase 2|
|Eurosarc Trial of Linsitinib in Advanced Ewing Sarcoma||European Commission||Phase 2|